
- Articles
Creating a culture of safety - the new Protect Duty
10 Sept 2025Security preparedness and the staged implementation of 'Martyn's law' for educational settings is a current focus of the DfE. Here's how VWV can help.

- Articles
Back to School: Top tips for SEND Governance
12 Sept 2025The Department for Education (DfE) reported on 12 June 2025 that over 1.7 million pupils in England have special educational needs (SEN), which is an increase of 93,000 (5.6%) since 2024.

- Articles
Mandatory ID verification will come into effect on 18 November 2025 - what do you need to do?
24 Sept 2025Have the trustees of your charitable company verified their identity for Companies House? Companies House has confirmed that the rollout for mandatory ID requirements will start on 18 November 2025.

- Articles
UK Life Sciences shows resilience and opportunity despite concerns over recent big pharma announcements
08 Oct 2025It's been a challenging few weeks for the UK life sciences sector. Following the breakdown of the talks with the Government to provide a more competitive reimbursement scheme for pharma, there have been a number of high-profile decisions that have created big concerns for the future of the sector. However, there have been some good news stories too, including a resilient message from MedCity - the life sciences arm of London and Partners, with whom VWV is a partner.

- Articles
UMF Grant Agreements - are you on the allocation list?
27 Oct 2025The Primary Care UMF offers an opportunity for GP practices to improve their premises. Securing the grant requires navigating complex legal agreements. Act promptly to meet these requirements to ensure your practice benefits from this investment.

- Articles
MHRA and NICE collaboration: A new era for accelerating patient access to medicines
04 Nov 2025The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have provided more details about a significant collaboration aimed at transforming the regulatory and health technology assessment processes in the UK. This MHRA and NICE partnership marks a pivotal step in expediting patient access to medicines while enhancing the UK’s position as a global leader in life sciences.